Respiratory Disease Testing Is Estimated To Witness High Growth Owing To Rapid Technological Advancements
![]() |
Respiratory Disease Testing |
Respiratory disease testing products effectively diagnoses various respiratory diseases like chronic obstructive pulmonary disease (COPD), lung cancer, asthma, and other lower respiratory tract infections through techniques like pulmonary function tests (PFT), chest imaging and smear tests. PFT helps measure lung capacity and evaluate lung functioning through spirometry and peak flow meter tests, while chest imaging techniques like X-ray, CT scan and MRI helps detect abnormalities in lungs. Moreover, tests like sputum smear examination evaluates presence of harmful bacteria or fungi causing respiratory infections.
The
global respiratory disease testing market is estimated to be valued at US$ 3232 Mn in 2023 and is expected to
exhibit a CAGR of 6.0% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Opportunity:
Rapid technological advancements is expected to drive the respiratory disease
testing market over the forecast period. Development of portable PFT devices
integrated with smart connectivity features enables remote monitoring of lung
functioning. Moreover, advancement in imaging techniques have led to
development of high resolution CT scans capable of precisely detecting even
tiny lung nodules. Emergence of advanced molecular diagnostic tests help
identify biomarkers and genetic mutations responsible for diseases. This
facilitates early and accurate diagnosis helping to improve patient outcomes.
Rapid automation of test processes using AI and machine learning is further
increasing efficiency and availability of respiratory disease testing products.
Overall, ongoing technological innovation is poised to augment market growth by
making respiratory disease testing more accessible and precise globally.
Porter's Analysis
Threat of new entrants: The respiratory disease testing market requires
high R&D investment and regulatory approvals which pose significant
barriers for new companies.
Bargaining power of buyers: Buyers
have moderate bargaining power due to the presence of several testing equipment
manufacturers.
Bargaining power of suppliers: Suppliers of raw materials and components
have moderate bargaining power due to minimum differentiation in products.
Threat of new substitutes: There is minimal threat from new substitutes due
to strong brand recognition of major players and regulated nature of the
market.
Competitive rivalry: The market is
highly competitive with the presence of both global and regional players.
SWOT Analysis
Strength: Non-invasive testing procedures and portable devices offer
convenience. Rising application in diagnosis of chronic respiratory diseases.
Weakness: High costs associated with
equipment, reagents and expertise required for respiratory disease testing.
Lack of awareness in developing nations.
Opportunity: Untapped growth
opportunities in developing countries. New product launches and collaborations
between regional and global players.
Threats: Stringent regulatory
approvals and quality certifications. Reimbursement issues in some markets.
Key Takeaways
The Global
Respiratory Disease Testing Market Share is expected to witness high
growth over the forecast period of 2023 to 2030. The global Respiratory Disease
Testing Market is estimated to be valued at US$ 3232 Mn in 2023 and is expected to exhibit a CAGR of 6.0% over the forecast period
2023 to 2030.
North
America currently dominates the market due to high healthcare expenditure and
technological advancements. However, Asia Pacific is expected to grow at the
fastest pace during the forecast period due to rising geriatric population,
growing pollution levels and increasing healthcare investments in developing
countries.
Key players operating in the respiratory disease testing market are Annandale
Distillery, Rocky Mountain Barrel Company, Exotic Barrels, Esty Inc., Midwest
Barrel Co., Mystic Barrels, Red Head Barrels, Kentucky Bourbon Barrel
(Independent Stave Company), Country Connection, and Kelvin Cooperage. These
key players are focusing on new product launches, collaborations and geographic
expansions to strengthen their market positions.
Explore more information on this topic, Please
visit @ https://www.rapidwebwire.com/respiratory-disease-testing-market-rises-to-be-a-key-disease-management-tool-by-surging-demand-for-point-of-care-diagnostic-devices
Comments
Post a Comment